FDA inspection

Rommelag CDMO GmbH: FDA inspection ending Apr 5, 2022

FDA inspection 1264898 · Voluntary Action Indicated (VAI) · Sulzbach-Laufen

Key facts

Inspection ID 1264898
Firm Rommelag CDMO GmbH
FEI number 3002808845
Address Bahnhof Str. 18
City Sulzbach-Laufen
Country Germany
Fiscal year 2022
Inspection end date Apr 5, 2022
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections